About US

Bioniz is an emerging biopharmaceutical company focused on discovering and developing novel peptide-based therapeutics for the treatment of immune diseases. Bioniz mission is to advance its lead asset into clinical trials and towards commercialization while continuing its cutting edge research and development on its other assets for different indications. Bioniz is interested in partnerships and collaborations to assist us advance our programs in clinical trials.